Study H6Q-MC-JCCB A Phase 2, Open-Label, Multicenter Study of Single- Agent Enzastaurin in Patients with Relapsed Cutaneous T-Cell Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2010
At a glance
- Drugs Enzastaurin (Primary)
- Indications Cutaneous T cell lymphoma
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 31 Mar 2010 Actual number of patients (25) added as reported by ClinicalTrials.gov record.
- 31 Mar 2010 Actual end date (1 Feb 2010) added as reported by ClinicalTrials.gov record.
- 31 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.